July 23, 2015
This week TheBodyPRO.com attended the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), in Vancouver, Canada. Here are our research highlights so far. Stay tuned for continuing coverage! To beat HIV, you have to follow the science!
An 18-year-old female has been able to maintain an undetectable viral load for more than 12 years after interrupting early antiretroviral therapy, according to a study presented at IAS 2015.
Final results revealed a 93% reduction in the rate of sexual HIV transmission in serodiscordant couples when the individual with HIV was taking antiretroviral therapy.
"Medical evidence is clear: All people living with HIV must have access to antiretroviral treatment upon diagnosis. Barriers to access in law, policy, and bias must be confronted and dismantled," declares the Vancouver Consensus, a consensus statement unveiled on the opening night of IAS 2015.
Earlier this year, we learned that the START study had found overwhelming evidence that beginning HIV antiretroviral therapy at any CD4 count was better than waiting. At IAS 2015, we got our first detailed look at the data.
The science is a little over my head at this point, but the preliminary results for this new approach are very promising. Using a method of gene editing known as CRISPR/Cas9, the researchers were able to cut out the proviral DNA fragment in latently infected T cells, which led to inactivation of HIV gene expression and replication -- meaning eradication.
Is there a development this week in HIV research that you think we missed? Send us a tip!
Warren Tong is the senior science editor for TheBody.com and TheBodyPRO.com.
Follow Warren on Twitter: @WarrenAtTheBody.
Copyright © 2015 Remedy Health Media, LLC. All rights reserved.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.